Blood Serum Metabolomics Using Comprehensive Two-Dimensional Gas Chromatography High Resolution Time-of-Flight Mass Spectromery

Significance of the Topic

The identification and quantification of serum metabolites after traumatic brain injury (TBI) is critical for developing rapid biomarkers and understanding pathophysiological changes. Blood‐borne metabolites can cross the blood–brain barrier and provide real‐time insight into brain injury severity, progression, and long‐term effects.

Objectives and Study Overview

This study aimed to apply one‐dimensional high‐resolution GC–TOFMS (GC-HRTMS) and comprehensive two‐dimensional GC×GC–HRTMS to pooled serum samples from moderate and severe TBI patients. Key goals included characterizing unknown metabolites, comparing 1D and 2D separations, and enhancing compound identification confidence.

Methodology and Instrumentation

Sample Preparation:

• Extract serum with methanol/water.
• Derivatize with methoxyamine in pyridine then MSTFA, each at 45 °C for 1 h.

Data Acquisition:

• GC columns: 30 m primary and 0.6 m secondary for GC×GC.
• Instruments: Pegasus HRT (GC–ToFMS) and Pegasus HRT 4D (GC×GC–ToFMS).
• Ionization: Electron Impact (EI) and Chemical Ionization (CI) up to 50 k resolution and 200 spectra/s.

Data Processing:

• High Resolution Deconvolution (HRD) for comprehensive peak finding and target analyte finding.
• Database searches (NIST, Wiley, Fiehn) for spectral matching.
• Accurate mass formula assignment and complementary EI/CI data to confirm identities.

Main Results and Discussion

GC×GC–HRTMS delivered superior chromatographic resolution, structured contour plots, and effective interference removal compared to 1D. In pooled sample M2, 42 metabolites were confidently identified, including amino acids, organic acids, lipids, sterols, and sugar derivatives. Down-regulation of branched-chain amino acids and up-regulation of short-chain carboxylic acids were observed in moderate and severe TBI. Derivatization expanded metabolome coverage and improved spectral similarity scores (>800). Processing of full TIC and AIC took under five minutes.

Benefits and Practical Applications

• High sensitivity and reproducibility for trace metabolite analysis.
• Rapid workflows without need for MS/MS fragmentation.
• Robust compound identification through accurate mass and dual ionization modes.
• Suitable for large clinical datasets and quantitative biomarker discovery.

Future Trends and Applications

Advances will include expanded spectral libraries, integration of MS/MS and ion mobility, automation in data processing, and cross‐platform multi-omics. Clinical translation of GC×GC–HRTMS metabolomics could enable point-of-care TBI diagnostics and personalized monitoring.

Conclusion

Comprehensive GC×GC–HRTMS combined with high‐resolution deconvolution provides a powerful platform for serum metabolomics in TBI. It enhances metabolite coverage, identification confidence, and throughput, facilitating biomarker research and clinical applications.

References

No specific reference list was provided in the original text.